A multicentre trial of Zostrum (5 percent idoxuridine in dimethyl sulphoxide) in herpes zoster.

摘要: Forty-six patients with herpes zoster were randomised into two groups treated DMSO alone and 5 percent IDU in DMSO, provided that treatment started within 48 hours of the appearance a rash. In group interval before pain improved was significantly shorter than control group, fewer new vesicles developed at three day follow up active compared group. These findings are agreement previously published work confirm usefulness Zostrum (5 DMSO) zoster.